AGP Executive Report
Last update: 3 hours agoPharma Reshoring Pressure: Trump says imported generic drugs will face 100% tariffs starting Aug. 2028, rising to 200% in 2029 unless makers shift production to the U.S., a move analysts warn could be “gargantuan” and raise costs for patients. Food & Materials Regulation: The FDA moved to revoke Orange B and propose revoking Citrus Red No. 2, continuing efforts to clean up outdated color additive authorizations. Critical Minerals Funding: The Commerce Department’s EDA awarded $38M to Missouri S&T’s critical minerals Tech Hub to strengthen domestic supply chains. Defense Manufacturing Scale-Up: CSG broke ground on Iowa’s Future Artillery Complex, aiming to produce up to 36,000 loaded 155mm rounds per month. Drone Industrial Base: ReconCraft and Ukraine’s Uforce plan to manufacture hundreds (possibly thousands) of Magura sea drones annually in the U.S., targeting South Carolina and Oregon. Antitrust Watch: Senators Jim Banks and Elizabeth Warren pushed an FTC probe into alleged price-fixing and monopolization in the fire truck manufacturing industry. Environmental Compliance Fight: AG Kwame Raoul joined a lawsuit challenging EPA’s rollback of HFC phaseout rules.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
Pseudo-journalism: Pink-slime
